LDH or NSE or LDH and NSE as pretreatment prognostic factors in small cell lung cancer? A commentary

Lung Cancer

Volumn 30, Issue 1, 2000, Pages 51-53

  Osterlind, K ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; CHROMOGRANIN A; LACTATE DEHYDROGENASE; NEURON SPECIFIC ENOLASE; TUMOR MARKER;

CANCER DIAGNOSIS; CANCER STAGING; CANCER SURVIVAL; DIAGNOSTIC VALUE; HUMAN; LUNG SMALL CELL CANCER; NOTE; PRIORITY JOURNAL; PROGNOSIS;

EID: 0033805877     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(00)00155-0     Document Type: Note

References (17)

1. Quoix E, Purohit A, Faller-Beau M, Moreau L, Oster JP, Pauli G. Comparative prognostic value of lactate dehydrogenase and neuron-specific enolase in small-cell lung cancer patients treated with platinum-based chemotherapy. Lung Cancer 2000;27:x–y
2. R.L. Souhami I. Bradbury D.M. Geddes S.G. Spiro P.G. Harper J.S. Tobias Prognostic significance of laboratory parameters measured at diagnosis in small cell carcinoma of the lung Cancer Res. 45 1985 2878 2882
3. K. Østerlind P.K. Andersen Prognostic factors in small cell lung cancer: multivariate model based on 778 patients treated with chemotherapy with or without irradiation Cancer Res. 46 1986 4189 4194
4. T. Cerny V. Blair H. Anderson V. Bramwell N. Thatcher Pretreatment prognostic factors and scoring system in 407 small-cell lung cancer patients Int. J. Cancer 39 1987 146 149
5. M.D. Vincent S.E. Ashley I.E. Smith Prognostic factors in small cell lung cancer: a simple prognostic index is better than conventional staging Eur. J. Cancer Clin. Oncol. 23 1987 1589 1599
6. J.P. Pignon R. Arriagada D.C. Ihde D.H. Johnson M.C. Perry R.L. Souhami A meta-analysis of thoracic radiotherapy for small cell lung cancer N. Engl. J. Med. 327 1992 1618 1624
7. A. Aupérin R. Arriagada J.-P. Pignon C.L. Péchoux A. Gregor R.J. Stephens Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission N. Engl. J. Med. 341 1999 476 484
8. A.T. Turrisi K. Kim R. Blum W.T. Sause R.B. Livingston R. Komaki Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide N. Engl. J. Med. 340 1999 265 271
9. M. Harding J. McAllister G. Hulks D. Vernon R. Monie J. Paul Neurone specific enolase (NSE) in small cell lung cancer: a tumour marker of prognostic significance? Br. J. Cancer 61 1990 605 607
10. P.W.M. Johnson S.P. Joel S. Love M. Butcher M.R. Pandian L. Squires Tumour markers for prediction of survival and monitoring of remission in small cell lung cancer Br. J. Cancer 67 1993 760 766
11. L.G.M. Jørgensen K. Østerlind H.H. Hansen E.H. Cooper The prognostic influence of serum neuron specific enolase in small cell lung cancer Br. J. Cancer 58 1988 805 807
12. L.G.M. Jørgensen Neuron specific enolase in small cell lung cancer. Clinical and biochemical evaluation Dan. Med. Bull. 46 1999 1 12
13. E. Quoix A. Charloux E. Popin G. Pauli Inability of serum neuron-specific enolase to predict disease extent in small cell lung cancer Eur. J. Cancer 29 1993 2250
14. L.G.M. Jørgensen K. Østerlind J. Genollá S.A. Gomm J.R. Hernández P.W.M. Johnson Serum neuron-specific enolase (S-NSE) and the prognosis in small-cell lung cancer (SCLC): a combined multivariable analysis on data from nine centres Br. J. Cancer 74 1996 463 467
15. L. Drivsholm L. Paloheimo K. Østerlind Chromogranin A, a significant prognostic factor in small cell lung cancer Br. J. Cancer 81 1999 667 671
16. Y. Miyake T. Kodama K. Yamaguchi Pro-gastrin-releasing peptide(31-98) is a specific tumor marker in patients with small cell lung carcinoma Cancer Res. 54 2000 2136 2140
17. L. Drivsholm K. Østerlind J. Holst Neuron specific enolase (NSE), pro-gastrin-releasing peptide (proGRP) and chromogranin A (chromA) are significant prognostic factors in small cell lung cancer (SCLC) Lung Cancer 11 1994 77